He is the Founder and MD of Cogent Group. He has 20+ years of Experience in Speciality Chemicals, Performance Chemicals, Key starting materials and API Intermediate industry. He has technical associations with Global Multinationals such as E-Merck, BASF, Jubilant Life Sciences, DSM Sino Chem, Neogen, Cipla Ltd etc...

He is a dynamic Entrepreneur having a sharp acumen of technical knowledge and experience. He is the first one to introduce Higee Technology in India for Specific Applications in Speciality Chemicals Division. Through his vision, Cogent has been able to adopt Flow Chemistry Technology at early stages for New Product Development and optimising the existing ones.

His Quest for New technologies takes him to the pinnacle of learning new dimensions in manufacturing operations and creates a paradigm shift. His exceptional sense of direction holds the beacon of light for the future.

He is the brother of Adarsh Shah & Co-Founder of the Cogent Group. He is a Science Grad in Industrial Chemistry from Ruia, completed his F-MBA from NMIMS, Mumbai & Executive MBA from Harvard Business School. He has a Strong Global Network & experience of 15+ Years in the Pharma/Specialty Chemical Industry.

Mr. Shah is a 2^nd Generation Entrepreneur & a Visionary. Prior to his present role, he has worked with Lupin Ltd, Gharda Chemicals & TDML (Therapeutic Drug Monitoring Lab). Through his robust connects in India and the US, he has built a distinguished career with experience in several businesses and cross-functions such as Generics, finance, sales and marketing, supply chain & operations, among others.

He is a recipient of the "Harvard Business School Alumni Challenge Award" in from Harvard Business School Boston, USA. He has Strong Market Networks Globally and Business Relationships with companies from China, South Korea, North America, Belgium, Basel, Singapore, Malaysia & MENA Region.

Dr. Zareen Delawar Hussain is the most diversified and pioneer Health care professional, entrepreneur and philanthropist in Bangladesh with significant accomplishments in all arena where she stepped. Professionally she is Cardiothoracic anesthesiologist and her 30 years learning, dedication and commitment made her distinctive, well connective and confident. From passion about adding meaningful values in terminally ill patients she played a significant role in advocating palliative care concepts in Bangladesh together with the team of Centre of Palliative Care in building a compassionate society. She is the General Secretary of Palliative Care Society of Bangladesh. She is an iconic first-generation female start up entrepreneur initiated Invicta Pharma Care Limited for bringing world hit high technology pharma products and medical devices in Bangladesh at affordable price. For her personal visionaries resourcefulness she introduced couple of world’s block blaster product in Bangladesh at nominal cost. Later she became a stake of mid size pharmaceutical Manufacturer for introducing specialized health care products. She is the founder Chairperson and Managing Director of Novo Invicta Specialized HealthCare Limited. Over the last decade, Dr. Zareen has become an influential voice in the country for establishing women empowerment, gender violence & stop child marriage. Currently she is the Vice Area Director of Zonta International of Area 2, District 25. She is the popular media personality who is anchoring various health related shows in most of the channels.

Dr. Zareen has a clear mindset and keen eyes to expand her pharma industry in the middle east through either acquisition, merger or technology transfer.

Dr. Detlef completed his PhD from Institute of Pharmaceutical Chemistry at Christian-Albrecht University Kiel and a techno-commercial acknowledged expert in CDMO. He is currently involved in a novel drug discovery and has out licensing, in licensing expertise. Dr. Detlef is based out of Germany. Apart from being in the technical area, Dr. Detlef has held several positions in the area of Business Development, Procurement, Quality. He has developed and implemented various global strategic projects at corporate level and is a regular speaker at various conferences and expert panels.

Dr. Mukund has Ph.D in organic chemistry from Georgetown University. He completed post-doctoral appointments at the University of Virginia and Harvard University, and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. He has been a recipient of three “Scientist of the Year Awards” and is on the Scientific Advisory Board of several corporations / foundations. Dr. Mukund holds / has had Adjunct Research Professor / Visiting Fellow / Visiting Scientist appointments at Caltech, Harvard, MIT, Northeastern, Northwestern, Princeton, Rutgers, Univ. of Chicago (USA), University of British Columbia (Canada), Cambridge, Strathclyde, (UK), College de France, Universite’ Louis Pasteur (France), ICT, CSIR, KHRC (India), and others. He provides synthetic chemistry and pharmaceutical development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. His research interests are in Drug Discovery and Development Process Chemistry Derived Medicinal Chemistry, Traditional Medicine derived New Chemical Entities. Dr. Mukund has demonstrated 33 years of research leadership and project management of multi-million dollar projects.